Global Point of care Molecular Diagnostics Market Analysis & Trends - Technology, Test Location, Application - Forecast to 2025

  • ID: 3971848
  • Report
  • Region: Global
  • 159 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abaxis Inc.
  • Abbott Laboratories
  • Alere Inc (Abbott)
  • Bayer Healthcare
  • bioMerieux
  • Bio-rad Laboratories
  • MORE
"Global Point of care Molecular Diagnostics Market Analysis & Trends - Technology (Microarray-based, Hybridization-based, PCR-based, Genetic Sequencing-based), Test Location (POC, OTC), Application (Endocrinology, Infectious, Prenatal Testing, Hematology) - Forecast to 2025"

The Global Point of care Molecular Diagnostics Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include rising investments in research and development increasing portfolio of Molecular POCT.

Based on Technology the Market is categorized into Microarray-based, Hybridization-based, PCR-based and Genetic Sequencing-based. Depending on the Test Location the market is segmented by POC(Point-of-care) and OTC (Over-the-counter).

Based on End User the Market is categorized into Hospitals, Assisted Living Healthcare Facilities, Decentralized Labs, Home-care and Other End Users. Depending on the Application the market is segmented by Endocrinology, Infectious Diseases, Prenatal Testing, Hematology, Oncology and Other Applications.

This industry report analyzes the global markets for Molecular Point of Care Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Molecular Point of Care Diagnostics Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abaxis Inc.
  • Abbott Laboratories
  • Alere Inc (Abbott)
  • Bayer Healthcare
  • bioMerieux
  • Bio-rad Laboratories
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Rising investments in research and development
3.1.2 Increasing portfolio of Molecular POCT
3.1.3 Recent Technological advancements in Point of care Molecular Diagnostics
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Point of care Molecular Diagnostics Market, By Technology
4.1 Microarray-based
4.1.1 Microarray-based Market Forecast to 2025 (US$ MN)
4.2 Hybridization-based
4.2.1 Hybridization-based Market Forecast to 2025 (US$ MN)
4.3 PCR-based
4.3.1 PCR-based Market Forecast to 2025 (US$ MN)
4.4 Genetic Sequencing-based
4.4.1 Genetic Sequencing-based Market Forecast to 2025 (US$ MN)

5 Point of care Molecular Diagnostics Market, By Test Location
5.1 POC(Point-of-care)
5.1.1 POC(Point-of-care) Market Forecast to 2025 (US$ MN)
5.2 OTC (Over-the-counter)
5.2.1 OTC (Over-the-counter) Market Forecast to 2025 (US$ MN)

6 Point of care Molecular Diagnostics Market, By End User
6.1 Hospitals
6.1.1 Hospitals Market Forecast to 2025 (US$ MN)
6.2 Assisted Living Healthcare Facilities
6.2.1 Assisted Living Healthcare Facilities Market Forecast to 2025 (US$ MN)
6.3 Decentralized Labs
6.3.1 Decentralized Labs Market Forecast to 2025 (US$ MN)
6.4 Home-care
6.4.1 Home-care Market Forecast to 2025 (US$ MN)
6.5 Other End Users
6.5.1 Other End Users Market Forecast to 2025 (US$ MN)

7 Point of care Molecular Diagnostics Market, By Application
7.1 Endocrinology
7.1.1 Endocrinology Market Forecast to 2025 (US$ MN)
7.2 Infectious Diseases
7.2.1 Infectious Diseases Market Forecast to 2025 (US$ MN)
7.3 Prenatal Testing
7.3.1 Prenatal Testing Market Forecast to 2025 (US$ MN)
7.4 Hematology
7.4.1 Hematology Market Forecast to 2025 (US$ MN)
7.5 Oncology
7.5.1 Oncology Market Forecast to 2025 (US$ MN)
7.6 Other Applications
7.6.1 Other Applications Market Forecast to 2025 (US$ MN)

8 Point of care Molecular Diagnostics Market, By Geography
8.1 North America
8.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
8.1.1.1 US
8.1.1.2 Canada
8.1.1.3 Mexico
8.2 Europe
8.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
8.2.1.1 France
8.2.1.2 Germany
8.2.1.3 Italy
8.2.1.4 Spain
8.2.1.5 UK
8.2.1.8 Rest of Europe
8.3 Asia Pacific
8.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 India
8.3.1.4 Australia
8.3.1.5 New Zealand
8.3.1.8 Rest of Asia
8.4 Middle East
8.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
8.4.1.1 Saudi Arabia
8.4.1.2 UAE
8.4.1.3 Rest of Middle East
8.5 Latin America
8.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
8.5.1.1 Argentina
8.5.1.2 Brazil
8.5.1.3 Rest of Latin America
8.6 Rest of the World (RoW)
8.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
8.6.1.1 Africa
8.6.1.2 Caribbean

9 Key Player Activities
9.1 Mergers & Acquisitions
9.2 Partnerships, Joint Venture’s, Collaborations and Agreements
9.3 Product Launch & Expansions
9.4 Other Activities

10 Leading Companies
10.1 Roche Diagnostics
10.2 OraSure Technologies Inc.
10.3 Danaher Corporation
10.4 Dako
10.5 Bio-rad Laboratories
10.6 bioMerieux
10.7 Bayer Healthcare
10.8 Alere Inc (Abbott)
10.9 Abbott Laboratories
10.10 Abaxis Inc.

List of Tables

Table 1 Global Point of care Molecular Diagnostics Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 3 Global Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 4 Global Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 5 Global Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 6 Global Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 7 Global Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 8 Global Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 9 Global Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 10 Global Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 11 Global Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 12 Global Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 13 Global Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 14 Global Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 15 Global Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 16 Global Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 17 Global Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 18 Global Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 19 Global Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 20 Global Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 21 Global Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 22 Global Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Table 23 North America Point of care Molecular Diagnostics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 24 North America Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 25 North America Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 26 North America Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 27 North America Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 28 North America Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 29 North America Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 30 North America Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 31 North America Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 32 North America Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 33 North America Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 34 North America Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 35 North America Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 36 North America Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 37 North America Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 38 North America Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 39 North America Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 40 North America Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 41 North America Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 42 North America Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 43 North America Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 44 North America Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Table 45 Europe Point of care Molecular Diagnostics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 46 Europe Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 47 Europe Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 48 Europe Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 49 Europe Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 50 Europe Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 51 Europe Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 52 Europe Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 53 Europe Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 54 Europe Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 55 Europe Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 56 Europe Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 57 Europe Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 58 Europe Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 59 Europe Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 60 Europe Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 61 Europe Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 62 Europe Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 63 Europe Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 64 Europe Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 65 Europe Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 66 Europe Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Table 67 Asia Pacific Point of care Molecular Diagnostics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 68 Asia Pacific Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 69 Asia Pacific Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 70 Asia Pacific Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 71 Asia Pacific Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 72 Asia Pacific Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 73 Asia Pacific Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 74 Asia Pacific Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 75 Asia Pacific Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 76 Asia Pacific Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 77 Asia Pacific Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 78 Asia Pacific Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 79 Asia Pacific Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 80 Asia Pacific Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 81 Asia Pacific Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 82 Asia Pacific Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 83 Asia Pacific Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 84 Asia Pacific Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 85 Asia Pacific Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 86 Asia Pacific Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 87 Asia Pacific Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 88 Asia Pacific Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Table 89 Middle East Point of care Molecular Diagnostics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 90 Middle East Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 91 Middle East Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 92 Middle East Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 93 Middle East Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 94 Middle East Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 95 Middle East Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 96 Middle East Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 97 Middle East Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 98 Middle East Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 99 Middle East Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 100 Middle East Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 101 Middle East Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 102 Middle East Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 103 Middle East Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 104 Middle East Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 105 Middle East Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 106 Middle East Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 107 Middle East Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 108 Middle East Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 109 Middle East Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 110 Middle East Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Table 111 Latin America Point of care Molecular Diagnostics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 112 Latin America Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 113 Latin America Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 114 Latin America Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 115 Latin America Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 116 Latin America Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 117 Latin America Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 118 Latin America Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 119 Latin America Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 120 Latin America Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 121 Latin America Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 122 Latin America Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 123 Latin America Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 124 Latin America Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 125 Latin America Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 126 Latin America Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 127 Latin America Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 128 Latin America Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 129 Latin America Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 130 Latin America Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 131 Latin America Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 132 Latin America Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Table 133 RoW Point of care Molecular Diagnostics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 134 RoW Point of care Molecular Diagnostics Market By Technology, Market Forecast (2013-2025) (US $MN)
Table 135 RoW Point of care Molecular Diagnostics Market By Microarray-based, Market Forecast (2013-2025) (US $MN)
Table 136 RoW Point of care Molecular Diagnostics Market By Hybridization-based, Market Forecast (2013-2025) (US $MN)
Table 137 RoW Point of care Molecular Diagnostics Market By PCR-based, Market Forecast (2013-2025) (US $MN)
Table 138 RoW Point of care Molecular Diagnostics Market By Genetic Sequencing-based, Market Forecast (2013-2025) (US $MN)
Table 139 RoW Point of care Molecular Diagnostics Market By Test Location, Market Forecast (2013-2025) (US $MN)
Table 140 RoW Point of care Molecular Diagnostics Market By POC(Point-of-care), Market Forecast (2013-2025) (US $MN)
Table 141 RoW Point of care Molecular Diagnostics Market By OTC (Over-the-counter), Market Forecast (2013-2025) (US $MN)
Table 142 RoW Point of care Molecular Diagnostics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 143 RoW Point of care Molecular Diagnostics Market By Hospitals, Market Forecast (2013-2025) (US $MN)
Table 144 RoW Point of care Molecular Diagnostics Market By Assisted Living Healthcare Facilities, Market Forecast (2013-2025) (US $MN)
Table 145 RoW Point of care Molecular Diagnostics Market By Decentralized Labs, Market Forecast (2013-2025) (US $MN)
Table 146 RoW Point of care Molecular Diagnostics Market By Home-care, Market Forecast (2013-2025) (US $MN)
Table 147 RoW Point of care Molecular Diagnostics Market By Other End Users, Market Forecast (2013-2025) (US $MN)
Table 148 RoW Point of care Molecular Diagnostics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 149 RoW Point of care Molecular Diagnostics Market By Endocrinology, Market Forecast (2013-2025) (US $MN)
Table 150 RoW Point of care Molecular Diagnostics Market By Infectious Diseases, Market Forecast (2013-2025) (US $MN)
Table 151 RoW Point of care Molecular Diagnostics Market By Prenatal Testing, Market Forecast (2013-2025) (US $MN)
Table 152 RoW Point of care Molecular Diagnostics Market By Hematology, Market Forecast (2013-2025) (US $MN)
Table 153 RoW Point of care Molecular Diagnostics Market By Oncology, Market Forecast (2013-2025) (US $MN)
Table 154 RoW Point of care Molecular Diagnostics Market By Other Applications, Market Forecast (2013-2025) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abaxis Inc.
  • Abbott Laboratories
  • Alere Inc (Abbott)
  • Bayer Healthcare
  • Bio-rad Laboratories
  • Dako
  • Danaher Corporation
  • OraSure Technologies Inc.
  • Roche Diagnostics
  • bioMerieux
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll